SEC Form 3 · accession 0001567619-18-003238
Gritstone Oncology, Inc. · GRTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Hawryluk
Officer — See Remarks
Period of report
Sep 27, 2018
Accepted (ET)
Sep 27, 2018 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001656634
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 143,224 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.60 | holding | — | — | — | Oct 27, 2018 | Aug 6, 2028 | Common Stock | 14,492 | — | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on September 27, 2018.
Remarks
Executive Vice President and Chief Business Officer